Acquisition by Kaplin Adam of 150000 shares of MyMD Pharmaceuticals subject to Rule 16b-3

MYMDDelisted Stock  USD 1.82  0.02  1.09%   
About 61% of MyMD Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in MyMD Pharmaceuticals suggests that many traders are alarmed regarding MyMD Pharmaceuticals' prospects. The current market sentiment, together with MyMD Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use MyMD Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Mymd Pharmaceuticals Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
MyMD insider trading alert for grant of employee stock option right to buy by Kaplin Adam, Chief Scientific Officer, on 9th of June 2023. This event was filed by Mymd Pharmaceuticals Inc with SEC on 2023-06-09. Statement of changes in beneficial ownership - SEC Form 4

MyMD Pharmaceuticals Fundamental Analysis

We analyze MyMD Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MyMD Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MyMD Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash And Equivalents

Cash And Equivalents Comparative Analysis

MyMD Pharmaceuticals is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

MyMD Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MyMD Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of MyMD Pharmaceuticals could also be used in its relative valuation, which is a method of valuing MyMD Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

MyMD Pharmaceuticals Related Equities

UBXUnity Biotechnology   4.17   
0%
75.0%
RXRXRecursion Pharmaceuticals   3.58   
0%
64.0%
GOVXGeoVax Labs   2.26   
0%
40.0%
DSGNDesign Therapeutics   2.25   
0%
40.0%
BOLTBolt Biotherapeutics   2.00   
0%
35.0%
NVCTNuvectis Pharma   1.53   
0%
27.0%
XBIOXenetic Biosciences   1.47   
0%
26.0%
REPLReplimune   1.30   
0%
23.0%
KZRKezar Life   0.94   
0%
16.0%
SRZNSurrozen   0.08   
0%
1.0%
AVIRAtea Pharmaceuticals   0.31   
5.0%
0%
LGNDLigand Pharmaceuticals   0.37   
6.0%
0%
KRONKronos Bio   1.04   
18.0%
0%
LRMRLarimar Therapeutics   1.25   
22.0%
0%
PASGPassage Bio   1.52   
27.0%
0%
LYELLyell Immunopharma   1.61   
28.0%
0%
ORICOric Pharmaceuticals   1.68   
30.0%
0%
NBYNovaBay Pharmaceuticals   1.89   
33.0%
0%
GOSSGossamer Bio   2.33   
41.0%
0%
KROSKeros Therapeutics   2.39   
42.0%
0%
REVBRevelation Biosciences   3.23   
58.0%
0%
LYRALyra Therapeutics   5.56   
100.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Consideration for investing in MyMD Stock

If you are still planning to invest in MyMD Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyMD Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Global Correlations
Find global opportunities by holding instruments from different markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
CEOs Directory
Screen CEOs from public companies around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios